UCSF Benioff Children's Hospital - Oakland
Blood and Marrow Transplantation Program
747 - 52nd Street
Oakland, CA 94609-1809
Direct phone: (510) 428-3374
Total transplants by cell source
- Marrow: 17
- PBSC: 5
- Cord Blood: 1
- Autologous (PBSC or Marrow): 18
About the center
Established in January 2000, the BMT program at UCSF Benioff Children's Hospital Oakland provides a comprehensive range of pediatric and young adult transplant and cellular therapy services in the San Francisco Bay Area, including referrals throughout northern California, nationally and internationally. Our comprehensive services are available throughout the transplant trajectory of care and include donor evaluation, recipient evaluation, intra-transplant care, donor collection, post-transplant care in a pediatric and young adult outpatient facility, and photopheresis for acute and chronic graft versus host disease. The center has now also expanded its care giving by participating in transplantation clinical trials and commercial products for patients with hemoglobinopathies (e.g., sickle cell and thalassemia)
This center has been performing allogeneic transplants since 2000 and has been an NMDP/Be The Match transplant center since June 2002.
Adult - Anu Agrawal, Nahal Lalefar, Mark Walters
Pediatric - Anu Agrawal, Nahal Lalefar, Mark Walters
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Comprehensive Sickle Cell Program
Comprehensive Thalassemia Program
Comprehensive Hematology & Oncology Program
Integrated Pediatric Palliative Care Program
Hospital-based school program
Child Life Services, Art Program & Music Therapy Program
Gene therapy clinical trials
Gene therapy commercial products
Ronald McDonald Family Support Services
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2018, 2019, 2020, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 27 patients.
The actual 1-year survival of these patients is 96.3%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 71.8% and 97.0%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2020 to December 31st, 2021 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2020 to December 31st, 2021 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
(510) 428-3885 (ext 2835)
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)